Robert J. Delaversano serves as Executive at ONCOSEC MEDICAL Inc, where they oversee executive responsibilities. Since joining the company, Robert J. Delaversano has executed 11 insider transactions totaling $4.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 9, 2023 involved selling 40 shares valued at $55.
Robert J. Delaversano currently holds 1,008 shares of ONCOSEC MEDICAL Inc (ONCS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Delaversano has been a net seller of ONCS stock. They have purchased $0 and sold $4.6K worth of shares.
Robert J. Delaversano's most recent insider trade was on Feb 9, 2023, when they sold 40 shares at $1.37 per share.
Get notified when new Form 4 filings are submitted
| $0.37 |
| Discretionary |
| Aug 5, 2022 | ONCS | $202 | Sale | 284 | $0.71 | Discretionary |
| May 6, 2022 | ONCS | $227 | Sale | 274 | $0.83 | Discretionary |
| Feb 9, 2022 | ONCS | $360 | Sale | 409 | $0.88 | Discretionary |
| Nov 1, 2021 | ONCS | $600 | Sale | 343 | $1.75 | Discretionary |
| Aug 2, 2021 | ONCS | $898 | Sale | 412 | $2.18 | Discretionary |
| May 3, 2021 | ONCS | $2.2K | Sale | 453 | $4.86 | Discretionary |
| Feb 1, 2021 | ONCS | $0 | Award | 8,750 | $N/A | Discretionary |
| May 29, 2020 | ONCS | $0 | Award | 25,362 | $N/A | Discretionary |
| May 29, 2020 | ONCS | $19.4K | Payment | 8,679 | $2.23 | Discretionary |